Weekly Policy Update: True Transparency and Medicare Stakeholder Input

Friday, February 16, 2018

Continue Reading

Vivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study

Monday, February 12, 2018


Weekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers

Friday, February 09, 2018

This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the future of our state as it relates to healthcare. Lt. Governor’s remarks were a great opportunity for our companies to hear from State leadership and ask top of mind questions. Throughout the day CBSA members heard a report on the Association’s policy priorities, heard from legislators about their priorities, learned how to best engage legislators throughout the session, and garnered insight on the value of advocacy. We wrapped up the day with a life science showcase, which was a great opportunity for the Colorado General Assembly talk to our members and learn about the exciting innovations in our industry.  

Colorado BioScience Association highlights state’s life-saving medical breakthroughs for lawmakers

Friday, February 09, 2018

Annual event brings health care innovators to share successes with legislators at the Capitol 
Continue Reading

Friday Policy Updates 2/2/2018

Friday, February 02, 2018

As things continue to be active and heat up over at the Colorado State Capitol, this week the Colorado BioScience Association took formal positions on three bills, while continuing to evaluate and make recommendations on legislation being introduced. Outlined below are further details - and encouragement to reach out to CBSA for your perspective.   

Friday Policy Updates 1/26/2018

Friday, January 26, 2018

Continue Reading

Colorado BioScience Association Highlights Medtech Disruption

Wednesday, January 24, 2018

Annual Medical Device Symposium discusses industry growth, innovation and federal policy outlook 
Continue Reading

Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

Tuesday, January 23, 2018


Friday Policy Update 1/19/2018

Friday, January 19, 2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until February 16th. Included in the CR is a 2-year retroactive suspension of the device tax and a 6-year reauthorization of Children’s Health Insurance Program (CHIP), the longest reauthorization in CHIP’s history. Both would have a significant positive impact to our industry. The bill is now in the Senate’s hands, which we anticipate a vote today before midnight. At this time, it is unclear if the Senate has enough votes to pass the CR. If the House version of the CR does not pass, Congress will look to pass a clean, multi-day CR and have further discussions on a larger package that would address immigration, budget caps, and other issues. If the multi-day CR is the route Congress takes, it is likely the medical device excise tax will not be included   

Millennials: Training Talent

Tuesday, January 16, 2018